Brittany W. Email & Phone Number

San Diego, CA, US

Currently, I provide leadership and direction for key programs, projects, and initiatives within the global DPDS organization. I also oversee global strategic initiatives and objectives related to cross-functional business planning and operations by providing coordination and change management support 3.6K+ employees.➟ I lead global teams across functions.

Concurrent to my DPDS role, I also lead our global postdoc program, including planning and executing local and global research symposia for 140+ Janssen R&D postdocs and PhD students.➟ Manage, mentor, and coach 25-40 postdoctoral fellows during various program phases, resulting in a dynamic and diverse community of high-potential early career scientists.➟.

Although I formally received this title of co-lead in 2022, my efforts in this role truly began in 2018. I partner with the 501c3 nonprofit organization, International Center for Professional Development, to create and execute a strategy to attract, recruit, and mentor early-career underrepresented scientists. ➟ Champion the strategy and execution of the.

As a scientist, I supported the development, maintenance, and growth of the Janssen Protein Degradation Drug Discovery (JPD3) group by devising and executing a strategy to advance internal programs from proof-of-concept (POC) to hit identification, which led to early successes in the organization. ➟ Directed a JPD3 multifunctional sub-team (5 FTEs) and.

➟ Led 3 projects and executed every phase to identify selective and potent NMDA receptor modulators to aid in the suppression of undesirable CNS side effects caused by Ketamine.➟ Spearheaded efforts of scale-ups and reaction modifications of drug candidates, which led to improved reaction yields and novel synthetic chemistry routes for important NMDA.

Brentford, Middlesex, GB

During my internship, I had the opportunity to develop SAR in the series of hPGDS inhibitors in which the rational design of compounds was executed using structure-based ligand designing and modern, synthetic organic chemistry techniques.

Bloomington, Indiana, US

My research concentrated on the enantioselective synthesis of cyclobutane derivatives using a novel chirality transfer [2+2] cycloaddition approach. This method has been used to access a variety of structurally-complex products/molecules of biological interest.

Morgantown, West Virginia, US

Doctor Of Philosophy (Ph.D.), Organic Chemistry

Bachelor Of Arts (Ba), Chemistry